Key facts
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Biotherapies
- ·The full record, as it builds
Funding rounds
No funding rounds for Biotherapies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Biotherapies
Operator of a mammastatin serum assay technology intended to screen breast cancer risk. The company is currently operating in stealth mode.
- Sector
- Healthcare
- HQ
- Ann Arbor, MI, United States
- Founded
- 1996
- Ownership
- Privately Held (backing)
Biotherapies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Biotherapies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Biotherapies in its N-PORT filings yet. We sweep new filings monthly.